LON:FDBK Feedback (FDBK) Share Price, News & Analysis → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free FDBK Stock Alerts GBX 100 -2.50 (-2.44%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range 97▼ 10050-Day Range 59▼ 14052-Week Range 55▼ 152.92Volume2,471 shsAverage Volume17,174 shsMarket Capitalization£13.33 millionP/E RatioN/ADividend Yield4.56%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Feedback alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Feedback Stock (LON:FDBK)Feedback plc, a medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging. Its products include Bleepa, a secure clinical communications and data viewing platform that facilitates the sharing of clinical-grade medical images; CareLocker, a patient centric cloud architecture that provides secure data portability; and Bleepa Box, a technology for sharing DICOM images and other clinical data over mobile networks with the company's dedicated cloud environment, CareLocker, for subsequent display and review within Bleepa. The company also offers Cadran, a picture archiving storage, management, and display system for medical images; TexRAD, a patent-protected algorithm that extracts and quantifies texture features in pre-existing medical images; and TexRAD Lung, a software tool for the analysis of lung cancer for clinical use. Feedback plc was incorporated in 1958 and is headquartered in London, the United Kingdom.Read More FDBK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FDBK Stock News HeadlinesApril 23, 2024 | americanbankingnews.comFeedback (LON:FDBK) Shares Cross Below Fifty Day Moving Average of $105.29March 7, 2024 | finance.yahoo.comWe're Keeping An Eye On Feedback's (LON:FDBK) Cash Burn RateApril 24, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? February 21, 2024 | lse.co.ukFeedback says interim revenue down, announces new pilot dealDecember 19, 2023 | lse.co.ukFeedback shares fall as eyes interim revenue decline; hails awardOctober 27, 2023 | sfgate.comWriting groups spark creativity, provide feedbackJune 6, 2023 | forbes.comFive Steps To Get Honest FeedbackMay 24, 2023 | forbes.comHard Feedback Is The Most Generous Act Of LeadershipApril 24, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? April 18, 2023 | forbes.comHow To Give Feedback On Someone's AppearanceMarch 23, 2023 | finance.yahoo.comWe Think Feedback (LON:FDBK) Can Afford To Drive Business GrowthMarch 10, 2023 | bbc.co.ukTypes of feedback - intrinsic and extrinsicMarch 1, 2023 | cbsnews.comBoulder wants feedback on snow removal in the cityOctober 14, 2022 | finance.yahoo.comWe're Interested To See How Feedback (LON:FDBK) Uses Its Cash Hoard To GrowSeptember 4, 2022 | lse.co.uk2022-23 First Quarter Fiscal UpdateSeptember 3, 2022 | lse.co.ukUpdate on proposed refinance and redemptionSeptember 3, 2022 | lse.co.ukCapital Metals Share ChatAugust 6, 2022 | lse.co.ukChina's Sanya holiday hotspot shuts duty-free malls, venues to curb COVIDJune 1, 2022 | proactiveinvestors.com.auFeedback sees full-year revenue ‘materially ahead’ of market forecastsMay 1, 2022 | lse.co.ukTOP NEWS: NatWest income surges in first quarter and improves outlookApril 16, 2022 | yahoo.comNational Water Dance to return April 23April 15, 2022 | lse.co.ukImmuPharma surges on success in latest trial of lupus treatmentApril 15, 2022 | finance.yahoo.comHere's Why We're Not Too Worried About Feedback's (LON:FDBK) Cash Burn SituationApril 12, 2022 | proactiveinvestors.com.auUK unemployment back to pre-pandemic level but employment remains flat as people leave workforceApril 12, 2022 | proactiveinvestors.comFeedback wins two more NHS contracts for Bleepa appApril 2, 2022 | proactiveinvestors.com.auProactive weekly oil and gas highlights: Pantheon, COPL, Chariot, 88 Energy and moreApril 1, 2022 | lse.co.ukMainz Biomed Completes Successful Pre-Submission Process with the U.S FDA for ColoAlert's Pivotal Clinical TrialSee More Headlines Receive FDBK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Feedback and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/18/2020Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolLON:FDBK CUSIPN/A CIKN/A Webwww.fbk.com Phone+44-1954-718072FaxN/AEmployees24Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-3,490,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-32.67% Return on Assets-21.47% Debt Debt-to-Equity RatioN/A Current Ratio6.52 Quick Ratio18.41 Sales & Book Value Annual Sales£1.02 million Price / Sales13.07 Cash FlowGBX 89.37 per share Price / Cash Flow1.12 Book ValueGBX 67 per share Price / Book1.49Miscellaneous Outstanding Shares13,330,000Free FloatN/AMarket Cap£13.33 million OptionableNot Optionable Beta0.79 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Thomas James Oakley B.Sc. (Age 35)CEO & Director Comp: $210.67kMr. Aneshkumar Ishwarbhai Patel C.A. (Age 43)CFO, Company Secretary & Director Comp: $177.35kMr. Stephen McAteerChief Operating OfficerMr. Michael Peter Hayball (Age 57)Chief Technology Officer Comp: $94.75kDr. Stephen BrownChief Information OfficerMs. Sarah BricknellCommercial and Legal AdvisorMr. Nicolas MayhewChief Sales & Marketing OfficerMore ExecutivesKey CompetitorsInduction Healthcare GroupLON:INHCCambridge CognitionLON:COGTrellus HealthLON:TRLSIQ-AILON:IQAIRenalytixLON:RENXView All CompetitorsInsidersAnnemijn EschauzierSold 5,422 sharesTotal: £47.23 M ($8,710.00/share) FDBK Stock Analysis - Frequently Asked Questions How have FDBK shares performed in 2024? Feedback's stock was trading at GBX 67.50 at the start of the year. Since then, FDBK stock has increased by 48.1% and is now trading at GBX 100. View the best growth stocks for 2024 here. How were Feedback's earnings last quarter? Feedback plc (LON:FDBK) posted its quarterly earnings results on Tuesday, February, 18th. The company reported ($26.00) earnings per share (EPS) for the quarter. When did Feedback's stock split? Feedback shares reverse split before market open on Friday, October 14th 2022. The 1-200 reverse split was announced on Friday, October 14th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. What other stocks do shareholders of Feedback own? Based on aggregate information from My MarketBeat watchlists, some companies that other Feedback investors own include Quadrise Fuels International (QFI), Apple Hospitality REIT (APLE), Advanced Oncotherapy (AVO), Deltic Energy Plc (CLNR.L) (CLNR), Haydale Graphene Industries (HAYD), Ilika (IKA), Open Text (OTEX), Prospect Capital (PSEC), Remote Monitored Systems (RMS) and 21512 (SAT.L) (SAT). How do I buy shares of Feedback? Shares of FDBK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:FDBK) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Feedback plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
